4-Chloro-3-[(3-chloro-4-methylphenyl)sulfamoyl]benzoic acid

Catalog No.: 
ACRWCO100
CAS No.: 
326023-00-1
Molecular Formula: 
C14H11Cl2NO4S
Molecular Weight: 
360.22
4-Chloro-3-[(3-chloro-4-methylphenyl)sulfamoyl]benzoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$72.00InquiryInquiry
100mg95%$104.00InquiryInquiry
250mg95%$137.00InquiryInquiry
1g95%$350.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Chloro-3-[(3-chloro-4-methylphenyl)sulfamoyl]benzoic acid
IUPAC Name4-chloro-3-(N-(3-chloro-4-methylphenyl)sulfamoyl)benzoic acid
MDL No.MFCD02700604
Molecular FormulaC14H11Cl2NO4S
Molecular Weight360.22
SMILESO=C(O)C1=CC=C(Cl)C(S(=O)(NC2=CC=C(C)C(Cl)=C2)=O)=C1
InChI KeyNVBDESMQYRNCMG-UHFFFAOYSA-N
SynonymBenzoic acid, 4-chloro-3-[[(3-chloro-4-methylphenyl)amino]sulfonyl]-
CAS No.326023-00-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501

Synthetic Route by SureRoute

1. ACRWCO100 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFINS437 route compound structure diagram
    ACFINS4377745-89-3In Stock
  2. Plus
  3. ACGIAP207 route compound structure diagram
    ACGIAP2072494-79-3In Stock
  4. Then
  5. ACRWCO100 route product structure diagram
    ACRWCO100326023-00-1
Inquiry

2. ACRWCO100 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRWCO100 route product structure diagram
    ACRWCO100326023-00-1
Inquiry

3. ACRWCO100 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRWCO100 route product structure diagram
    ACRWCO100326023-00-1
Inquiry

Comments (0)